Verenigde Staten - Engels - NLM (National Library of Medicine)

bryant ranch prepack - albuterol sulfate (unii: 021sef3731) (albuterol - unii:qf8svz843e) - albuterol 2 mg - albuterol tablets are indicated for the relief of bronchospasm in adults and children 6 years of age and older with reversible obstructive airway disease. albuterol tablets are contraindicated in patients with a history of hypersensitivity to albuterol, or any of its components.

Verenigde Staten - Engels - NLM (National Library of Medicine)

armstrong pharmaceuticals, inc. - albuterol (unii: qf8svz843e) (albuterol - unii:qf8svz843e) - aerosol, metered - 90 ug - albuterol inhalation aerosol is indicated for the prevention and relief of bronchospasm in patients 4 years of age and older with reversible obstructive airway disease, and for the prevention of exercise induced bronchospasm in patients 4 years of age and older. albuterol inhalation aerosol can be used with or without concomitant steroid therapy. albuterol inhalation aerosol is contraindicated in patients with a history of hypersensitivity to albuterol or any of its components. before using your albuterol inhalation aerosol, read complete instructions carefully. children should use albuterol inhalation aerosol under adult supervision, as instructed by the patient's doctor. the blue adapter supplied with albuterol inhalation aerosol should not be used with any other product canisters, and adapters from other products should not be used with an albuterol inhalation aerosol canister. the refill canister is to be used only with the blue albuterol inhalation aerosol adapter id#720. dosage use only as directed by y

Verenigde Staten - Engels - NLM (National Library of Medicine)

a-s medication solutions - albuterol sulfate (unii: 021sef3731) (albuterol - unii:qf8svz843e) - albuterol 2.5 mg in 3 ml - albuterol sulfate inhalation solution is indicated for the relief of bronchospasm in patients 2 years of age and older with reversible obstructive airway disease and acute attacks of bronchospasm. albuterol sulfate inhalation solution is contraindicated in patients with a history of hypersensitivity to any of its components. albuterol sulfate inhalation solution 0.083% 2 note: this is a unit-dose vial. no dilution is required. read complete instructions carefully before using. - remove the vial from the foil pouch. - twist the cap completely off the vial and squeeze the contents into the nebulizer reservoir (figure 1). - connect the nebulizer reservoir to the mouthpiece or face mask (figure 2). - connect the nebulizer to the compressor. - sit in a comfortable, upright position; place the mouthpiece in your mouth (figure 3) (or put on the face mask); and turn on the compressor. - breathe as calmly, deeply and evenly as possible until no more mist is formed in the nebulizer chamber (about 5 to 15 minu

Verenigde Staten - Engels - NLM (National Library of Medicine)

carilion materials management - albuterol sulfate (unii: 021sef3731) (albuterol - unii:qf8svz843e) - albuterol 2 mg in 5 ml - albuterol sulfate syrup is indicated for the relief of bronchospasm in adults and children 2 years of age and older with reversible obstructive airway disease. albuterol sulfate syrup is contraindicated in patients with a history of hypersensitivity to albuterol or any of its components.

Verenigde Staten - Engels - NLM (National Library of Medicine)

bausch & lomb incorporated - albuterol sulfate (unii: 021sef3731) (albuterol - unii:qf8svz843e) - solution - albuterol sulfate inhalation solution is indicated for the relief of bronchospasm in patients 2 years of age and older with reversible obstructive airway disease and acute attacks of bronchospasm. albuterol sulfate inhalation solution is contraindicated in patients with a history of hypersensitivity to albuterol or any of its components. albuterol sulfate inhalation solution, 0.5%* *potency expressed as albuterol read complete instructions carefully before using. 1. draw the appropriate volume of albuterol sulfate inhalation solution, 0.5% into the specially marked dropper that comes with each multidose bottle. for children 12 years of age and under, the volume is based upon body weight. use the dropper volume prescribed by your doctor. 2. squeeze the solution into the nebulizer reservoir through the appropriate opening, taking care not to touch the tip of the dropper. 3. add sterile normal saline solution, as your doctor has directed. a general guideline for the amount of saline to add is: for children us

Verenigde Staten - Engels - NLM (National Library of Medicine)

remedyrepack inc. - levalbuterol hydrochloride (unii: wdq1526qjm) (levalbuterol - unii:edn2nbh5ss) - levalbuterol inhalation solution is indicated for the treatment or prevention of bronchospasm in adults, adolescents, and children 6 years of age and older with reversible obstructive airway disease. levalbuterol inhalation solution is contraindicated in patients with a history of hypersensitivity to levalbuterol or racemic albuterol. reactions have included urticaria, angioedema, rash, bronchospasm, anaphylaxis, and oropharyngeal edema [see warnings and precautions ( 5.6) ]. risk summary there are no adequate and well-controlled studies of levalbuterol inhalation solution in pregnant women. there are clinical considerations with the use of levalbuterol inhalation solution in pregnant women [see clinical considerations]. following oral administration of levelbuterol hcl to pregnant rabbits, there was no evidence of teratogenicity at doses up to 25 mg/kg/day [approximately 108 times the maximum recommended human daily inhalation dose (mrhdid) of levalbute

Verenigde Staten - Engels - NLM (National Library of Medicine)

impax generics - levalbuterol hydrochloride (unii: wdq1526qjm) (levalbuterol - unii:edn2nbh5ss) - levalbuterol 1.25 mg in 3 ml

Verenigde Staten - Engels - NLM (National Library of Medicine)

actavis pharma, inc. - levalbuterol hydrochloride (unii: wdq1526qjm) (levalbuterol - unii:edn2nbh5ss) - levalbuterol 0.31 mg in 3 ml

Verenigde Staten - Engels - NLM (National Library of Medicine)

cardinal health - levalbuterol hydrochloride (unii: wdq1526qjm) (levalbuterol - unii:edn2nbh5ss) - levalbuterol 1.25 mg in 0.5 ml

Verenigde Staten - Engels - NLM (National Library of Medicine)

nucare pharmaceuticals,inc. - levalbuterol hydrochloride (unii: wdq1526qjm) (levalbuterol - unii:edn2nbh5ss) - levalbuterol inhalation solution, usp is indicated for the treatment or prevention of bronchospasm in adults, adolescents, and children 6 years of age and older with reversible obstructive airway disease. levalbuterol inhalation solution, usp is contraindicated in patients with a history of hypersensitivity to levalbuterol or racemic albuterol. reactions have included urticaria, angioedema, rash, bronchospasm, anaphylaxis, and oropharyngeal edema [see warnings and precautions (5.6) ]. teratogenic effects: pregnancy category c. there are no adequate and well-controlled studies of levalbuterol inhalation solution, usp in pregnant women. because animal reproduction studies are not always predictive of human response, levalbuterol inhalation solution, usp should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. during worldwide marketing experience, various congenital anomalies, including cleft palate and limb defects, have been reporte